Research peptide tablets wholesale: tablet items by compound
Short answerResearch peptide tablets wholesale from International Wholesale Peptides covers fourteen tablet items, listed by compound and content per tablet with the bottle count. They are sold only to verified research institutions, laboratories and trade resellers, with a certificate of analysis for every lot.

- Category
- Tablets
- Items listed
- 14
- Pack
- Bottles of 30, 60 or 90 tablets, by item
- How items are named
- By compound and content per tablet
- Buyers
- Verified research institutions, laboratories and trade resellers
- First order
- From US$10,000 made to order; evaluation order from US$2,500
The Tablets category lists the solid, non-vial items in the research-use-only catalogue. Each item is named by its compound and its content per tablet, not by a product name. This page covers research peptide tablets wholesale: the fourteen items listed, who may buy them, the documents per lot and how to order.
What is in this category
The table gives the compounds in each tablet and the catalogue strength, written as the content per tablet.
| Item, by compound | Catalogue strength per tablet | Pack |
|---|---|---|
| BPC-157 | 500 mcg | 30 tablets |
| BPC-157 + KPV + larazotide | 500 mcg / 500 mcg / 500 mcg | 30 tablets |
| 5-Amino-1MQ | 50 mg | 30 tablets |
| 5-Amino-1MQ + SLU-PP-332 | 50 mg / 1 mg | 30 tablets |
| SLU-PP-332 | 1 mg | 30 tablets |
| SLU-PP-332 + BAM-15 | 1 mg / 10 mg | 30 tablets |
| Dihexa | 10 mg | 30 tablets |
| GHK-Cu | 2 mg | 30 tablets |
| Epitalon | 3 mg | 30 tablets |
| Tesofensine | 500 mcg | 30 or 60 tablets |
| Tesofensine + dihexa | 250 mcg / 5 mg | 60 tablets |
| Dihexa + tesofensine + BPC-157 | 10 mg / 250 mcg / 125 mcg | 60 tablets |
| GLP-1 S + tesofensine | 5 mg / 500 mcg | 30 tablets |
| Orforglipron | 6 mg | 90 tablets |
Linked names have a specification sheet with the chemical identity of the compound. The sheets describe the compound itself and are written for the vial form; the tablet item is described by the quote and the certificate.
Not every item is a peptide. 5-Amino-1MQ, SLU-PP-332, BAM-15, dihexa, tesofensine and orforglipron are synthetic small molecules. They are filed in this category by format. The certificate states the identity of each named compound in a lot.
Five items are restricted. Tesofensine is an investigational compound with no approval, as of November 2026. Orforglipron is the active ingredient of an FDA-approved prescription medicine, approved on 1 April 2026; the catalogue item is research-grade material described by chemical identity only, and it is not that medicine. GLP-1 S is a catalogue name used as a code; the identity of each lot is stated on its certificate of analysis. The items that contain tesofensine, orforglipron or GLP-1 S are supplied to verified research institutions only. Further GLP-1 S tablet items are listed on the GLP Research Compounds page.
Names are generic. IWP identifies a tablet item by compound and content on the quote, the label and the certificate. Consumer-style product names are not used in this catalogue.
The table describes contents only. A strength is the stated content of one tablet. It is a pack description for purchasing and stock control. The catalogue makes no statement about use, and no preparation or use information is given.
The format itself, including what is stated about tablet manufacture, is described on the oral tablets format page. Other non-vial categories are Dissolving Strips and Liquid Sprays.

Who can buy and how it is supplied
Tablet items in this category are sold to verified research institutions, laboratories, and the trade resellers that supply them, such as distributors and importers. Every buyer passes business verification before a quote is issued. IWP does not sell to individuals.
For research use only. Not for human or veterinary use. The label, the certificate and the invoice carry that restriction, and a reseller is expected to pass it on unchanged to its own verified customers. The restriction describes the intended use of the goods. It does not change the rules of a destination country, so IWP ships only where a lawful route exists for the product and the buyer, and confirms that route in writing before taking an order.
Items are supplied as finished tablets in bottles, described on the tablets format page. The quote names the origin statement of the lot and the composition per unit. Pack sizes, minimums and lead times for this format are stated on the quote.
Documents with every lot
Every lot ships with a certificate of analysis that names the testing laboratory and identifies each named compound in the lot. The tests reported for this format, and the content stated per tablet, are listed on the quote, so a buyer can check them against an internal specification before ordering. The lot number on the label can be checked against its certificate with the lot lookup.
| Document | What it states |
|---|---|
| Certificate of analysis | Testing laboratory, identity of each named compound, lot number, retest or expiry date |
| Quote | Composition per tablet, pack, origin statement, tests reported for the format |
| Packing list | Lot numbers, quantities, shipping conditions |
Ordering research peptide tablets wholesale
Ordering follows one sequence: application, business verification, quote, order. Prices are not published. The full trade price list and the current stock list are sent with account approval. Price is set by order value in four bands. A made-to-order first order starts at US$10,000, and one evaluation order of stock-list items from US$2,500 is allowed per account. Orders are prepaid by bank wire or ACH. Pack quantities and price breaks for this format are stated on the quote. Stock-list items leave in 2 to 5 business days, and most product is made to order in about 3 weeks.
The full conditions are in the wholesale terms. Accounts are opened through the application page. The other categories are listed on the research-use-only catalogue page.
Frequently asked questions
Which tablet items are in the catalogue?
Fourteen items. Nine are in bottles of 30: BPC-157; BPC-157 with KPV and larazotide; 5-Amino-1MQ; 5-Amino-1MQ with SLU-PP-332; SLU-PP-332; SLU-PP-332 with BAM-15; dihexa; GHK-Cu; and Epitalon. Five more are tesofensine, two tesofensine combinations, GLP-1 S with tesofensine, and orforglipron.
Are all tablet items peptides?
No. 5-Amino-1MQ, SLU-PP-332, BAM-15, dihexa, tesofensine and orforglipron are synthetic small molecules, filed in this category by format. The certificate of analysis for each lot names the testing laboratory and identifies each named compound, so a receiving laboratory can check the contents against the label.
Who can buy from the Tablets category?
Verified research institutions, laboratories, and trade resellers such as distributors and importers that supply them. Every account passes business verification before a quote is issued. IWP does not sell to individuals, and items in this category are sold for laboratory research and not for use in humans or animals.
What pack size are tablets supplied in?
Most catalogue items are bottles of 30 tablets; some are 60 or 90, as the table shows. Case quantities, price breaks, minimums and lead times for this format are stated on the quote after business verification. A made-to-order first order starts at US$10,000 across all items on the order.
Are prices published for this category?
No. International Wholesale Peptides does not publish prices. Buyers apply, pass business verification and receive a quote that names the origin statement of the lot and the pack. The trade price list is sent with account approval. A made-to-order first order starts at US$10,000, a one-time evaluation order of stock-list items starts at US$2,500, and orders are prepaid by bank wire or ACH.
Where do you ship items in this category?
Only where a lawful route exists for the product and the buyer, normally through a licensed importer in the destination country. IWP confirms the route in writing before taking an order. IWP supplies worldwide and assesses every country on request.

